Restarting Emergent’s production of the J&J shot would revitalize efforts to get the single-dose vaccine to many Americans.
Related posts:
FDA fights for independence in Trump administration’s final days
Biden dresses down his Covid team over plans to speed vaccinations
States struggle for control of chaotic vaccine rollout
Trump misses 20 million Covid shot target
Biden admin reveals plans for first 25 million donated vaccine doses
U.S. senators promise vaccines for Taiwan amid dispute with China
Biden admin preps for next pandemic as Delta variant surges
NIH director: ‘We want to avoid lockdowns at all costs’
New York City to mandate vaccines for indoor restaurants, gyms, performances
Dems plot to squeeze health care promises into social spending bill
WHO says measures used against Delta should work for Omicron
Judge blocks Biden’s vaccine mandate for federal contractors
